Terms: = Prostate cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Treatment
17784 results:
1. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer.
Scheipner L; Baudo A; Jannello LMI; Siech C; de Angelis M; Tian Z; Saad F; Shariat SF; Briganti A; Chun FKH; Carmignani L; De Cobelli O; Mischinger J; Ahyai S; Karakiewicz PI
World J Urol; 2024 Apr; 42(1):269. PubMed ID: 38679642
[TBL] [Abstract] [Full Text] [Related]
2. Salvage Radiotherapy PSMA PET/CT-guided in Men With PSA Recurrence.
Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
[TBL] [Abstract] [Full Text] [Related]
3. treatment of Osteoporosis in Men on Androgen Deprivation Therapy in Japan.
Nishimoto H; Inui A; Mifune Y; Yamaura K; Bando Y; Okamura Y; Hara T; Terakawa T; Kuroda R
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674197
[No Abstract] [Full Text] [Related]
4. Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy: a single-center study.
Jahnen M; Amiel T; Kirchoff F; Büchler JW; Herkommer K; Rothe K; Meissner VH; Gschwend JE; Lunger L
World J Urol; 2024 Apr; 42(1):260. PubMed ID: 38664275
[TBL] [Abstract] [Full Text] [Related]
5. Salvage prostate intensity modulated radiation therapy after cryotherapy failure.
Perennec T; Rogé M; Hetet JF; Colls P; Guimas V; Rio E; Vaugier L; Supiot S
Sci Rep; 2024 Apr; 14(1):9148. PubMed ID: 38644367
[TBL] [Abstract] [Full Text] [Related]
6. [Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
Jin Y; Zhai ZW; Sun LT; Xia PD; Hu H; Jiang CQ; Zhao BC; Qu H; Qian Q; Dai Y; Yao HW; Wang ZJ; Han JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):403-411. PubMed ID: 38644246
[No Abstract] [Full Text] [Related]
7. Surgical management of rectal cancer with synchronous treatment of prostate cancer.
Brière R; Martin AG; Letarte F; Fournier FR; Bouchard P; Drolet S
Langenbecks Arch Surg; 2024 Apr; 409(1):133. PubMed ID: 38642125
[TBL] [Abstract] [Full Text] [Related]
8. Patterns of Care for Medicare Beneficiaries With Metastatic prostate cancer.
Filson CP; Richards TB; Ekwueme DU; Howard DH
Urol Pract; 2024 May; 11(3):489-497. PubMed ID: 38640419
[TBL] [Abstract] [Full Text] [Related]
9. [Influence factors of erectile dysfunction in patients with localized prostate cancer after radical surgery].
Wang SH; Shi XQ; Ma MF; Jin XX; Zhao XD; Zhou YL; Gu YF; Hu J; Dong N; Dong J; Xu S
Zhonghua Nan Ke Xue; 2023 Dec; 29(12):992-999. PubMed ID: 38639951
[TBL] [Abstract] [Full Text] [Related]
10. [Application of 1470 nm semiconductor laser in the treatment of benign prostatic hyperplasia in ultra-aged patients].
Wu D; Yi XM; Wei HX; Zhang KX; Shi CJ; Shi XQ; Xu ZY; Fu D
Zhonghua Nan Ke Xue; 2023 Sep; 29(9):831-836. PubMed ID: 38639597
[TBL] [Abstract] [Full Text] [Related]
11. Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy.
Rodler S; Danninger D; Eismann L; Kazmierczak PM; Jokisch F; Li M; Becker A; Kretschmer A; Stief C; Westhofen T
World J Urol; 2024 Apr; 42(1):242. PubMed ID: 38635030
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of the anticancer effects exerted by 5-fluorouracil and heme oxygenase-1 inhibitor hybrids in HTC116 colorectal cancer cells.
Salerno L; Notaro A; Consoli V; Affranchi F; Pittalà V; Sorrenti V; Vanella L; Giuliano M; Intagliata S
J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2337191. PubMed ID: 38634597
[TBL] [Abstract] [Full Text] [Related]
13. A pictorial view on false positive findings of
Dancheva Z; Chausheva S; Stoeva T; Dyankova M; Yordanova T; Chaushev B; Marinov R; Nikolov V; Abushev P; Todorov G; Dimitrova E; Klisarova A; Anakievski D
Hell J Nucl Med; 2024; 27(1):16-26. PubMed ID: 38629815
[TBL] [Abstract] [Full Text] [Related]
14. Identifying predictors of COVID-related delays in cancer-specific medical care.
Greteman BB; Del Vecchio NJ; Garcia-Auguste CJ; Kahl AR; Gryzlak BM; Chrischilles EA; Charlton ME; Nash SH
Cancer Med; 2024 Apr; 13(8):e7183. PubMed ID: 38629238
[TBL] [Abstract] [Full Text] [Related]
15. Role of oxygen reserve index monitoring in patients undergoing robot-assisted radical prostatectomy: a retrospective study.
Ryu JH; Jeon YT; Sim KM; Lee S; Oh AY; Koo CH
World J Urol; 2024 Apr; 42(1):232. PubMed ID: 38613597
[TBL] [Abstract] [Full Text] [Related]
16. Supported exercise TrAining for Men wIth prostate cancer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation.
McNaught E; Reale S; Bourke L; Brown JE; Collinson M; Day F; Hewison J; Farrin AJ; Ibeggazene S; Innes AQ; Mason E; Meads D; Scope A; Taylor C; Taylor SJ; Turner RR; Rosario DJ;
Trials; 2024 Apr; 25(1):257. PubMed ID: 38610058
[TBL] [Abstract] [Full Text] [Related]
17. [Mechanism study on the effect of androgen antagonism in prostate cancer].
Song X; Song Q; Wang R; Zuo QJ; Zhang ZY
Zhonghua Nan Ke Xue; 2023 May; 29(5):402-408. PubMed ID: 38602755
[TBL] [Abstract] [Full Text] [Related]
18. Predictors of postoperative storage symptoms in male patients with lower urinary tract symptoms: A retrospective analysis of prostate surgery for benign prostatic enlargement.
Ito H; Takanashi M; Fukazawa T; Takizawa H; Hioki M; Shinoki R; Kawahara T; Makiyama K; Kobayashi K
Low Urin Tract Symptoms; 2024 May; 16(3):e12512. PubMed ID: 38602061
[TBL] [Abstract] [Full Text] [Related]
19. Clinical safety and efficacy of microwave ablation for small renal masses.
Foret A; Haaga CB; Jain S; Baumgartner CO; Escott M; Henderson BR; O'Brien ST; Delacroix SE; Gills JRR; Westerman ME
Int Braz J Urol; 2024; 50(3):277-286. PubMed ID: 38598830
[TBL] [Abstract] [Full Text] [Related]
20. Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide.
Baser O; Samayoa G; Dwivedi A; AlSaleh S; Cigdem B; Kizilkaya E
Acta Oncol; 2024 Apr; 63():137-146. PubMed ID: 38591349
[TBL] [Abstract] [Full Text] [Related]
[Next]